ROS stress in cancer cells and therapeutic implications

Drug Resistance Updates

Volumn 7, Issue 2, 2004, Pages 97-110

  Pelicano, Helene ^a   Carney, Dennis ^a   Huang, Peng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Anticancer agents; Apoptosis; Cancer; Mitochondria; Reactive oxygen species (ROS)

Indexed keywords

2 METHOXYESTRADIOL; AMINOTRIAZOLE; ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; ASCORBIC ACID; BLEOMYCIN; BORTEZOMIB; BUTHIONINE SULFOXIMINE; CISPLATIN; DAUNORUBICIN; DOXORUBICIN; EMODIN; ETACRYNIC ACID; FENRETINIDE; MALEIC ACID DIETHYL ESTER; MENADIONE; MITOCHONDRIAL DNA; PARAQUAT; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE; THIOMALIC ACID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CANCER CELL DESTRUCTION; CANCER RESISTANCE; CANCER THERAPY; CARCINOGENESIS; CELL METABOLISM; DNA DAMAGE; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESPONSE; DRUG SELECTIVITY; DRUG SENSITIVITY; ELECTRON TRANSPORT; HUMAN; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

EID: 2942593991     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drup.2004.01.004     Document Type: Review

References (156)

1. Ames, B.N., 1989. Endogenous DNA damage as related to cancer and aging. Mutat. Res. 214, 41-46.
2. Amorino, G.P., Freeman, M.L., Choy, H., 2000. Enhancement of radiation effects in vitro by the estrogen metabolite 2-methoxyestradiol. Radiat Res. 153, 384-391.
3. Asumendi, A., Morales, M.C., Alvarez, A., Arechaga, J., Perez-Yarza, G., 2002. Implication of mitochondria-derived ROS and cardiolipin peroxidation in N-(4-hydroxyphenyl)refinamide-induced apoptosis. Br. J. Cancer 86, 1951-1956.
4. Augenlicht, L.H., Heerdt, B.G., 2001. Mitochondria: integrators in tumorigenesis? Nat. Genet. 28, 104-105.
5. Bachleitner-Hofmann, T., Kees, M., Gisslinger, H., 2002. Arsenic trioxide: acute promyelocytic leukemia and beyond. Leuk. Lymphoma 43, 1535-1540.
6. Baliga, R., Ueda, N., Walker, P.D., Shah, S.V., 1999. Oxidant mechanisms in toxic acute renal failure. Drug Metab. Rev. 31, 971-997.
7. Behrend, L., Henderson, G., Zwacka, R.M., 2003. Reactive oxygen species in oncogenic transformation. Biochem. Soc. Trans. 31, 1441-1444.
8. Beinert, T., Binder, D., Stuschke, M., Jorres, R.A., Oehm, C., Fleischhacker, M., Sezer, O., Mergenthaler, H.G., Werner, T., Possinger, K., 1999. Oxidant-induced lung injury in anticancer therapy. Eur. J. Med. Res. 4, 43-53.
9. Benhar, M., Dalyot, I., Engelberg, D., Levitzki, A., 2001. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol. Cell Biol. 21, 6913-6926.
10. Boveris, A., Chance, B., 1973. The mitochondrial generation of hydrogen peroxide: general properties and effect of hyperbaric oxygen. Biochem. J. 134, 707-716.
11. Boya, P., Morales, M.C., Gonzalez-Polo, R.A., Andreau, K., Gourdier, I., Perfettini, J.L., Larochette, N., Deniaud, A., Baran-Marszak, F., Fagard, R., Feuillard, J., Asumendi, A., Raphael, M., Pau, B., Brenner, C., Kroemer, G., 2003. The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family. Oncogene 22, 6220-6230.
12. Brar, S.S., Corbin, Z., Kennedy, T.P., 2003. NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. Am. J. Physiol. Cell Physiol. 285, C353-C369.
13. Bras, A., Sanches, R., Cristovao, L., Fidalgo, P., Chagas, C., Mexia, J., Leitao, N., Rueff, J., 1999. Oxidative stress in familial adenomatous polyposis. Eur. J. Cancer Prev. 8, 305-310.
14. Brown, G.C., Borutaite, V., 2002. Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radic. Biol. Med. 33, 1440-1450.
15. Burdon, R.H., 1995. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. 18, 775-794.
16. Cai, J., Wallace, D.C., Zhivotovsky, B., Jones, D.P., 2000. Separation of cytochrome c-dependent caspase activation from thiol-disulfide redox change in cells lacking mitochondrial DNA. Free Radic. Biol. Med. 29, 334-342.
17. Carew, J.S., Huang, P., 2002. Mitochondrial defects in cancer. Mol. Cancer 1, 1-9 (Epub).
18. Carew, J.S., Zhou, Y., Albitar, M., Carew, J.D., Keating, M.J., Huang, P., 2003. Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications. Leukemia 17, 1437-1447.
19. Carmody, R.J., Cotter, T.G., 2001. Signalling apoptosis: a radical approach. Redox. Rep. 6, 77-90.
20. Chan, W.H., Yu, J.S., 2000. Inhibition of UV irradiation-induced oxidative stress and apoptotic biochemical changes in human epidermal carcinoma A431 cells by genistein. J. Cell. Biochem. 78, 73-84.
21. Chen, G.Q., Zhu, J., Shi, X.G., Ni, J.H., Zhong, H.J., Si, G.Y., Jin, X.L., Tang, W., Li, X.S., Xong, S.M., Shen, Z.X., Sun, G.L., Ma, J., Zhang, P., Zhang, T.D., Gazin, C., Naoe, T., Chen, S.J., Wang, Z.Y., Chen, Z., 1996. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 88, 1052-1061.
22. Chiou, C.C., Chang, P.Y., Chan, E.C., Wu, T.L., Tsao, K.C., Wu, J.T., 2003. Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers. Clin. Chim. Acta 334, 87-94.
23. Chomyn, A., Attardi, G., 2003. MtDNA mutations in aging and apoptosis. Biochem. Biophys. Res. Commun. 304, 519-529.
24. Cobbs, C.S., Levi, D.S., Aldape, K., Israel, M.A., 1996. Manganese superoxide dismutase expression in human central nervous system tumors. Cancer Res. 56, 3192-3195.
25. Copeland, W.C., Wachsman, J.T., Johnson, F.M., Penta, J.S., 2002. Mitochondrial DNA alterations in cancer. Cancer Invest. 20, 557-569.
26. Dai, J., Weinberg, R.S., Waxman, S., Jing, Y., 1999. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93, 268-277.
27. Davies, K.J., 1999. The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life 48, 41-47.
28. Davis, Jr., W., Ronai, Z., Tew, K.D., 2001. Cellular thiols and reactive oxygen species in drug-induced apoptosis. J. Pharmacol. Exp. Ther. 296, 1-6.
29. Davison, K., Cote, S., Mader, S., Miller, W.H., 2003. Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines. Leukemia 17, 931-940.
30. Devi, G.S., Prasad, M.H., Saraswathi, I., Raghu, D., Rao, D.N., Reddy, P.P., 2000. Free radicals antioxidant enzymes and lipid peroxidation in different types of leukemias. Clin. Chim. Acta 293, 53-62.
31. Dipple, A., 1995. DNA adducts of chemical carcinogens. Carcinogenesis 16, 437-441.
32. Dizdaroglu, M., 1991. Chemical determination of free radical-induced damage to DNA. Free Rad. Biol. Med. 10, 225-242.
33. Dorward, A., Sweet, S., Moorehead, R., Singh, G., 1997. Mitochondrial contributions to cancer cell physiology: redox balance, cell cycle, and drug resistance. J. Bioenerg. Biomembr. 29, 385-392.
34. Ernst, P., 1999. Review article: the role of inflammation in the pathogenesis of gastric cancer. Aliment Pharmacol. Ther. 13, 13-18.
35. Faderl, S., Kantarjian, H., Estey, E., Verstovsek, S., Garcia-Manero, G., Kwari, M., Callander, N., Emanuel, P., Piro, L., Keck, J., Jameson, A., Patel, K., Brown, G.L., Estrov, Z., 2003. Hematological improvement following treatment with TLK199 (a novel glutathione analog inhibitor of GST P1-1) in myelodysplastic syndrome (MDS): interim results of a phase 1-2a study. Blood 102, 426a.
36. Feinendegen, L.E., 2002. Reactive oxygen species in cell responses to toxic agents. Hum. Exp. Toxicol. 21, 85-90.
37. Fliss, M.S., Usadel, H., Caballero, O.L., Wu, L., Buta, M.R., Eleff, S.M., Jen, J., Sidransky, D., 2002. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287, 2017-2019.
38. Fojo, T., 2002. p53 as a therapeutic target: unresolved issues on the road to cancer therapy targeting mutant p53. Drug Resist. Updates 5, 209-216.
39. Fridovich, I., 1995. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 64, 97-112.
40. Gabaizadeh, R., Staecker, H., Liu, W., Van De Water, T.R., 1997. BDNF protection of auditory neurons from cisplatin involves changes in intracellular levels of both reactive oxygen species and glutathione. Brain Res. Mol. Brain Res. 50, 71-78.
41. Gianni, M., Koken, M.H., Chelbi-Alix, M.K., Benoit, G., Lanotte, M., Chen, Z., de The, H., 1998. Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells. Blood 91, 4300-4310.
42. Golab, J., Nowis, D., Skrzycki, M., Czeczot, H., Baranczyk-Kuzma, A., Wilczynski, G.M., Makowski, M., Mroz, P., Kozar, K., Kaminski, R., Jalili, A., Kopec, M., Grzela, T., Jakobisiak, M., 2003. Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol. A superoxide dismutase inhibitor. J. Biol. Chem. 278, 407-414.
43. Gopalakrishna, R., Jaken, S., 2000. Protein kinase C signaling and oxidative stress. Free Radic. Biol. Med. 28, 1349-1361.
44. Goto, H., Takahashi, H., Fujii, H., Ikuta, K., Yokota, S., 2003. N-(4-Hydroxyphenyl)retinamide (4-HPR) induces leukemia cell death via generation of reactive oxygen species. Int. J. Hematol. 78, 219-225.
45. Gouaze, V., Mirault, M.E., Carpentier, S., Salvayre, R., Levade, T., Andrieu-Abadie, N., 2001. Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells. Mol. Pharmacol. 60, 488-496.
46. Grad, J.M., Bahlis, N.J., Reis, I., Oshiro, M.M., Dalton, W.S., Boise, L.H., 2001. Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells. Blood 98, 805-813.
47. Halliwell, B., Gutteridge, J., 1999. Free Radicals in Biology and Medicine, 3rd ed. Oxford University Press Inc., New York, NY, U.S.A.
48. Haufel, T., Bauer, G., 2001. Transformation of rat fibroblasts by TGF-beta and EGF induces sensitivity for intercellular induction of apoptosis. Anticancer Res. 21, 2617-2628.
49. Helbock, H.J., Beckman, K.B., Shigenaga, M.K., Walter, P.B., Woodall, A.A., Yeo, H.C., Ames, B.N., 1998. DNA oxidation matters: the HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine. Proc. Natl. Acad. Sci. U.S.A. 95, 288-293.
50. Hensley, K., Robinson, K.A., Gabbita, S.P., Salsman, S., Floyd, R.A., 2000. Reactive oxygen species, cell signaling, and cell injury. Free Radic. Biol. Med. 28, 1456-1462.
51. Higuchi, Y., 2003. Chromosomal DNA fragmentation in apoptosis and necrosis induced by oxidative stress. Biochem. Pharmacol. 66, 1527-1535.
52. Hileman, E.O., Achanta, G., Huang, P., 2001. Superoxide dismutase: an emerging target for cancer therapeutics. Expert Opin. Ther. Targets 5, 679-710.
53. Hileman, E.O., Liu, J., Albitar, M., Keating, M.J., Huang, P., 2003. Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemother. Pharmacol. (Epub ahead of print).
54. Hlavata, L., Aguilaniu, H., Pichova, A., Nystrom, T., 2003. The oncogenic RAS2(val19) mutation locks respiration, independently of PKA, in a mode prone to generate ROS. EMBO J. 22, 3337-3345.
55. Holmgren, A., 1985. Thioredoxin. Annu. Rev. Biochem. 54, 237-271.
56. Holmgren, A., 2000. Antioxidant function of thioredoxin and glutaredoxin systems. Antioxid. Redox Signal 2, 811-820.
57. Huang, P., Feng, L., Oldham, E.A., Keating, M.J., Plunkett, W., 2000. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407, 390-395.
58. Hug, H., Strand, S., Grambihler, A., Galle, J., Hack, V., Stremmel, W., Krammer, P.H., Galle, P.R., 1997. Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J. Biol Chem. 272, 28191-28193.
59. Hussain, S.P., Hofseth, L.J., Harris, C.C., 2003. Radical causes of cancer. Nat. Rev. Cancer 3, 276-285.
60. Iida, T., Furuta, A., Kawashima, M., Nishida, J., Nakabeppu, Y., Iwaki, T., 2001. Accumulation of 8-oxo-2′-deoxyguanosine and increased expression of hMTH1 protein in brain tumors. Neuro-oncology 3, 73-81.
61. Irani, K., Xia, Y., Zweier, J.L., Sollott, S.J., Der, C.J., Fearon, E.R., Sundaresan, M., Finkel, T., Goldschmidt-Clermont, P.J., 1997. Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts. Science 275, 1649-1652.
62. Ishikawa, M., Yaginuma, Y., Hayashi, H., Shimizu, T., Endo, Y., Taniguchi, N., 1990. Reactivity of a monoclonal antibody to manganese superoxide dismutase with human ovarian carcinoma. Cancer Res. 50, 2538-2542.
63. Jackson, A.L., Loeb, L.A., 2001. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat. Res. 477, 7-21.
64. Janssen, A.M., Bosman, C.B., Kruidenier, L., Griffioen, G., Lamers, C.B., van Krieken, J.H., van de Velde, C.J., Verspaget, H.W., 1999. Superoxide dismutases in the human colorectal cancer sequence. J. Cancer Res. Clin. Oncol. 125, 327-335.
65. Janssen, A.M., Bosman, C.B., van Duijn, W., Oostendorp-van de Ruit, M.M., Kubben, F.J., Griffioen, G., Lamers, C.B., van Krieken, J.H., van de Velde, C.J., Verspaget, H.W., 2000. Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. Clin. Cancer Res. 6, 3183-3192.
66. Jaruga, P., Zastawny, T.H., Skokowski, J., Dizdaroglu, M., Olinski, R., 1994. Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett. 341, 59-64.
67. Jiang, S., Cai, J., Wallace, D.C., Jones, D.P., 1999. Cytochrome c-mediated apoptosis in cells lacking mitochondrial DNA. Signaling pathway involving release and caspase 3 activation is conserved. J. Biol. Chem. 274, 29905-29911.
68. Jing, Y., Dai, J., Chalmers-Redman, R.M., Tatton, W.G., Waxman, S., 1999. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 94, 2102-2111.
69. Joshi, B., Li, L., Taffe, B.G., Zhu, Z., Wahl, S., Tian, H., Ben-Josef, E., Taylor, J.D., Porter, A.T., Tang, D.G., 1999. Apoptosis induction by a novel anti-prostate cancer compound, BMD 188 (a fatty acid-containing hydroxamic acid), requires the mitochondrial respiratory chain. Cancer Res. 59, 4343-4355.
70. Jung, K., Seidel, B., Rudolph, B., Lein, M., Cronauer, M.V., Henke, W., Hampel, G., Schnorr, D., Loening, S.A., 1997. Antioxidant enzymes in malignant prostate cell lines and in primary cultured prostatic cells. Free Radic. Biol. Med. 23, 127-133.
71. Kanbagli, O., Ozdemirler, G., Bulut, T., Yamaner, S., Aykac-Toker, G., Uysal, M., 2000. Mitochondrial lipid peroxides and antioxidant enzymes in colorectal adenocarcinoma tissues. Jpn. J. Cancer Res. 91, 1258-1263.
72. Kang, D., Hamasaki, N., 2003. Mitochondrial oxidative stress and mitochondrial DNA. Clin. Chem. Lab. Med. 41, 1281-1288.
73. Kim, J.Y., Ahn, H.J., Ryu, J.H., Suk, K., Park, J.H., 2004. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1α. J. Exp. Med. 199, 113-124.
74. Kondo, S., Toyokuni, S., Iwasa, Y., Tanaka, T., Onodera, H., Hiai, H., Imamura, M., 1999. Persistent oxidative stress in human colorectal carcinoma, but not in adenoma. Free Radic. Biol. Med. 27, 401-410.
75. Kong, Q., Lillehei, K.O., 1998. Antioxidant inhibitors for cancer therapy. Med Hypotheses 51, 405-409.
76. Kong, Q., Beel, J.A., Lillehei, K.O., 2000. A threshold concept for cancer therapy. Med. Hypotheses 55, 29-35.
77. Konstantinov, A.A., Peskin, A.V., Popova, Eyu., Khomutov, G.B., Ruuge, E.K., 1987. Superoxide generation by the respiratory chain of tumor mitochondria. Biochim. Biophys. Acta 894, 1-10.
78. Kroemer, G., Reed, J.C., 2000. Mitochondrial control of cell death. Nat. Med. 6, 513-519.
79. Kroemer, G., Dallaporta, B., Resche-Rigon, M., 1998. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60, 619-642.
80. Kuchino, Y., Mori, F., Kasai, H., Inoue, H., Iwai, S., Miura, K., Ohtsuka, E., Nishimura, S., 1987. Misreading of DNA templates in containing 8-hydroxydeoxyguanosine at the modified base and at the adjacent residues. Nature 327, 77-79.
81. Kumimoto, H., Yamane, Y., Nishimoto, Y., Fukami, H., Shinoda, M., Hatooka, S., Ishizaki, K., 2004. Frequent somatic mutations of mitochondrial DNA in esophageal squamous cell carcinoma. Int. J. Cancer 108, 228-231.
82. Kuppusamy, P., Afeworki, M., Shankar, R.A., Coffin, D., Krishna, M.C., Hahn, S.M., Mitchell, J.B., Zweier, J.L., 1998. In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model. Cancer Res. 58, 1562-1568.
83. Kuppusamy, P., Li, H., Ilangovan, G., Cardounel, A.J., Zweier, J.L., Yamada, K., Krishna, M., Mitchell, J.B., 2002. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res. 62, 307-312.
84. Lambert, C., Thews, O., Biesalski, H.K., Vaupel, P., Kelleher, D.K., Frank, J., 2002. 2-Methoxyestradiol enhances reactive oxygen species formation and increases the efficacy of oxygen radical generating tumor treatment. Eur. J. Med. Res. 7, 404-414.
85. Ling, Y.H., Liebes, L., Zou, Y., Perez-Soler, R., 2003. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells. J. Biol. Chem. 278, 33714-33723.
86. Liu, H., Nishitoh, H., Ichijo, H., Kyriakis, J.M., 2000. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol. Cell. Biol. 20, 2198-2208.
87. Lloyd, D.R., Phillips, D.H., Carmichael, P.L., 1997. Generation of putative intrastrand cross-links and strand breaks in DNA by transition metal ion-mediated oxygen radical attack. Chem. Res. Toxicol. 10, 393-400.
88. Mallis, R.J., Buss, J.E., Thomas, J.A., 2001. Oxidative modification of H-ras: S-thiolation and S-nitrosylation of reactive cysteines. Biochem. J. 355, 145-153.
89. Mansat-de Mas, V., Bezombes, C., Quillet-Mary, A., Bettaieb, A., D'orgeix, A.D., Laurent, G., Jaffrezou, J.P., 1999. Implication of radical oxygen species in ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicin. Mol. Pharmacol. 56, 867-874.
90. Marklund, S.L., Westman, N.G., Lundgren, E., Roos, G., 1982. Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res. 42, 1955-1961.
91. Marshall, H.E., Merchant, K., Stamler, J.S., 2000. Nitrosation and oxidation in the regulation of gene expression. FASEB J. 14, 1889-1900.
92. Martin, K.R., Barrett, J.C., 2002. Reactive oxygen species as double-edged swords in cellular processes: low-dose cell signaling versus high-dose toxicity. Hum. Exp. Toxicol. 21, 71-75.
93. Martindale, J.L., Holbrook, N.J., 2002. Cellular response to oxidative stress: signaling for suicide and survival. J. Cell Physiol. 192, 1-15.
94. Matsuzaki, T., Sakanashi, M., Nakasone, J., 2002. Effects of glutathione S-transferase inhibitors on nitroglycerin action in pig isolated coronary arteries. Clin. Exp. Pharmacol. Physiol. 29, 1091-1095.
95. McCord, J.M., 1995. Superoxide radical: controversies, contradictions, and paradoxes. Proc. Soc. Exp. Biol. Med. 209, 112-117.
96. Miller, Jr., W.H., 2002. Molecular targets of arsenic trioxide in malignant cells. Oncologist 7, 14-29.
97. Miyajima, A., Nakashima, J., Yoshioka, K., Tachibana, M., Tazaki, H., Murai, M., 1997. Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells. Br. J. Cancer. 76, 206-210.
98. Mooberry, S.L., 2003. Mechanism of action of 2-methoxyestradiol: new developments. Drug Resist. Updates 6, 355-361.
99. Morel, I., Lescoat, G., Cillard, J., Pasdeloup, N., Brissot, P., Cillard, P., 1990. Kinetic evaluation of free malondialdehyde and enzyme leakage as indices of iron damage in rat hepatocyte cultures. Involvement of free radicals. Biochem. Pharmacol. 39, 1647-1655.
100. Morin, P.J., 2003. Drug resistance and the microenvironment: nature and nurture. Drug Resist. Updates 6, 169-172.
101. Murrell, G.A., Francis, M.J., Bromley, L., 1990. Modulation of fibroblast proliferation by oxygen free radicals. Biochem. J. 265, 659-665.
102. Nicotera, T.M., Privalle, C., Wang, T.C., Oshimura, M., Barrett, J.C., 1994. Differential proliferative responses of Syrian hamster embryo fibroblasts to paraquat-generated superoxide radicals depending on tumor suppressor gene function. Cancer Res. 54, 3884-3888.
103. Nishiura, T., Suzuki, K., Kawaguchi, T., Nakao, H., Kawamura, N., Taniguchi, M., Kanayama, Y., Yonezawa, T., Iizuka, S., Taniguchi, N., 1992. Elevated serum manganese superoxide dismutase in acute leukemias. Cancer Lett. 62, 211-215.
104. Niu, C., Yan, H., Yu, T., Sun, H.P., Liu, J.X., Li, X.S., Wu, W., Zhang, F.Q., Chen, Y., Zhou, L., Li, J.M., Zeng, X.Y., Yang, R.R., Yuan, M.M., Ren, M.Y., Gu, F.Y., Cao, Q., Gu, B.W., Su, X.Y., Chen, G.Q., Xjong, S.M., Zhang, T., Waxman, S., Wang, Z.Y., Chen, Z., Hu, J., Shen, Z.X., Chen, S.J., 1999. Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood 94, 3315-3324.
105. Oberley, L.W., Bize, I.B., Sahu, S.K., Leuthauser, S.W., Gruber, H.E., 1978. Superoxide dismutase activity of normal murine liver, regenerating liver, and H6 hepatoma. J. Natl. Cancer Inst. 61, 375-379.
106. O'Dwyer, P.J., Hamilton, T.C., LaCreta, F.P., Gallo, J.M., Kilpatrick, D., Halbherr, T., Brennan, J., Bookman, M.A., Hoffman, J., Young, R.C., Comis, R.L., Ozols, R.F., 1996. Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer. J. Clin. Oncol. 14, 249-256.
107. Okamoto, K., Toyokuni, S., Uchida, K., Ogawa, O., Takenewa, J., Kakehi, Y., Kinoshita, H., Hattori-Nakakuki, Y., Hiai, H., Yoshida, O., 1994. Formation of 8-hydroxy-2′-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. Intl. J. Cancer 58, 825-829.
108. Olinski, R., Zastawny, T., Budzbon, J., Skokowski, J., Zegarski, W., Dizaroglu, M., 1992. DNA base modifications in chromatin of human cancerous tissues. FEBS Lett. 309, 193-198.
109. Paddenberg, R., Goldenberg, A., Faulhammer, P., Braun-Dullaeus, R.C., Kummer, W., 2003. Mitochondrial complex II is essential for hypoxia-induced ROS generation and vasoconstriction in the pulmonary vasculature. Adv. Exp. Med. Biol. 536, 163-169.
110. Park, S.Y., Chang, I., Kim, J.Y., Kang, S.W., Park, S.H., Singh, K., Lee, M.S., 2004. Resistance of mitochondrial DNA-depleted cells against cell death: Role of mitochondrial superoxide dismutase. J. Biol. Chem. 279, 7512-7520.
111. Pelicano, H., Feng, L., Zhou, Y., Carew, J.S., Hileman, E.O., Plunkett, W., Keating, M.J., Huang, P., 2003. Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J. Biol. Chem. 278, 37832-37839.
112. Preeta, R., Nair, R.R., 1999. Stimulation of cardiac fibroblast proliferation by cerium: a superoxide anion-mediated response. J. Mol. Cell Cardiol. 31, 1573-1580.
113. Preuss, M., Girnun, G.D., Darby, C.J., Khoo, N., Spector, A.A., Robbins, M.E., 2000. Role of antioxidant enzyme expression in the selective cytotoxic response of glioma cells to gamma-linolenic acid supplementation. Free Radic. Biol. Med. 28, 1143-1156.
114. Punnonen, K., Ahotupa, M., Asaishi, K., Hyoty, M., Kudo, R., Punnonen, R., 1994. Antioxidant enzyme activities and oxidative stress in human breast cancer. J. Cancer Res. Clin. Oncol. 120, 374-377.
115. Randerath, K., Randerath, E., Smith, C.V., Chang, J., 1996. Structural origins of bulky oxidative DNA adducts (type III-compounds) as deduced by oxidation of oligonucleotides of known sequence. Chem. Res. Toxicol. 9, 247-254.
116. Richter, C., Gogvadze, V., Laffranchi, R., Schlapbach, R., Schweizer, M., Suter, M., Walter, P., Yaffee, M., 1995. Oxidants in mitochondria: from physiology to diseases. Biochim. Biophys. Acta 1271, 67-74.
117. Sade, H., Sarin, A., 2004. Reactive oxygen species regulate quiescent T-cell apoptosis via the BH3-only proapoptotic protein BIM. Cell Death. Differ. (Epub ahead of print).
118. Sasada, T., Iwata, S., Sato, N., Kitaoka, Y., Hirota, K., Nakamura, K., Nishiyama, A., Taniguchi, Y., Takabayashi, A., Yodoi, J., 1996. Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity. J. Clin. Invest. 97, 2268-2276.
119. Sastre, J., Pallardo, F.V., Vina, J., 2000. Mitochondrial oxidative stress plays a key role in aging and apoptosis. IUBMB Life 49, 427-435.
120. Saybasili, H., Yuksel, M., Haklar, G., Yalcin, A.S., 2001. Effect of mitochondrial electron transport chain inhibitors on superoxide radical generation in rat hippocampal and striatal slices. Antioxid. Redox Signal. 3, 1099-1104.
121. Schafer, F.Q., Buettner, G.R., 2001. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Rad. Biol. Med. 30, 1191-1212.
122. Schimmel, M., Bauer, G., 2002. Proapoptotic and redox state-related signaling of reactive oxygen species generated by transformed fibroblasts. Oncogene 21, 5886-5896.
123. Schwab, M., 1998. Amplification of oncogenes in human cancer cells. Bioessays 20, 473-479.
124. Senthil, K., Aranganathan, S., Nalini, N., 2004. Evidence of oxidative stress in the circulation of ovarian cancer patients. Clin. Chim. Acta 339, 27-32.
125. Serrano, J., Palmeira, C.M., Kuehl, D.W., Wallace, K.B., 1999. Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration. Biochim. Biophys. Acta 1411, 201-205.
126. Shen, Z.X., Chen, G.Q., Ni, J.H., Li, X.S., Xiong, S.M., Qiu, Q.Y., Zhu, J., Tang, W., Sun, G.L., Yang, K.Q., Chen, Y., Zhou, L., Fang, Z.W., Wang, Y.T., Ma, J., Zhang, P., Zhang, T.D., Chen, S.J., Chen, J., Wang, Z.Y., 1997. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89, 3354-3360.
127. Shibutani, S., Takeshita, M., Grollman, A.P., 1991. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 349, 431-434.
128. Singh, K.K., Russell, J., Sigala, B., Zhang, T., Williams, J., Keshav, K.F., 1999. Mitochondrial DNA determines the cellular response to cancer therapeutic agents. Oncogene 18, 6641-6646.
129. Sordet, O., Rebe, C., Leroy, I., Bruey, J.M., Garrido, C., Miguet, C., Lizard, G., Plenchette, S., Corcos, L., Solary, E., 2001. Mitochondria-targeting drugs arsenic trioxide and Ionidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis. Blood 97, 3931-3940.
130. Stadtman, E.R., 1990. Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic. Biol. Med. 9, 315-325.
131. Staniek, K., Gille, L., Kozlov, A.V., Nohl, H., 2002. Mitochondrial superoxide radical formation is controlled by electron bifurcation to the high and low potential pathways. Free Radic. Res. 36, 381-387.
132. Storey, K.B., 1996. Oxidative stress: animal adaptations in nature. Braz. J. Med. Biol. Res. 29, 1715-1733.
133. Suh, Y.A., Arnold, R.S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A.B., Griendling, K.K., Lambeth, J.D., 1999. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401, 79-82.
134. Sun, X.Z., Vinci, C., Makmura, L., Han, S., Tran, D., Nguyen, J., Hamann, M., Grazziani, S., Sheppard, S., Gutova, M., Zhou, F., Thomas, J., Momand, J., 2003. Formation of disulfide bond in p53 correlates with inhibition of DNA binding and tetramerization. Antioxid. Redox Signal. 5, 655-665.
135. Suzuki, S., Higuchi, M., Proske, R.J., Oridate, N., Hong, W.K., Lotan, R., 1999. Implication of mitochondria-derived reactive oxygen species, cytochrome c and caspase-3 in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. Oncogene 18, 6380-6387.
136. Swartz, H.M., Gutierrez, P.L., 1977. Free radical increases in cancer: evidence that there is not a real increase. Science 198, 936-938.
137. Szatrowski, T.P., Nathan, C.F., 1991. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51, 794-798.
138. Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D., 1998. The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. 141, 1423-1432.
139. Tosetti, F., Vene, R., Arena, G., Morini, M., Minghelli, S., Noonan, D.M., Albini, A., 2003. N-(4-hydroxyphenyl)retinamide inhibits retinoblastoma growth through reactive oxygen species-mediated cell death. Mol. Pharmacol. 63, 565-573.
140. Toyokuni, S., 1998. Oxidative stress and cancer: the role of redox regulation. Biotherapy 11, 147-154.
141. Toyokuni, S., Okamoto, K., Yodoi, J., Hiai, H., 1995. Persistent oxidative stress in cancer. FEBS Lett. 358, 1-3.
142. Tsang, W.P., Chau, S.P., Kong, S.K., Fung, K.P., Kwok, T.T., 2003. Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis. Life Sci. 73, 2047-2058.
143. Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T.K., Hampton, G.M., Wahl, G.M., 2002. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol. Cell 9, 1031-1044.
144. Van Driel, B.E., Lyon, H., Hoogenraad, D.C., Anten, S., Hansen, U., Van Noorden, C.J., 1997. Expression of CuZn- and Mn-superoxide dismutase in human colorectal neoplasms. Free Radic. Biol. Med. 23, 435-444.
145. Vasilevskaya, I., O'Dwyer, P.J., 2003. Role of Jun and Jun kinase in resistance of cancer cells to therapy. Drug Resist. Updates 6, 147-156.
146. Vignais, P.V., 2002. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol. Life Sci. 59, 1428-1459.
147. Wambi-kiesse, C.O., Katusic, Z.S., 1999. Inhibition of copper/zinc superoxide dismutase impairs NO-mediated endothelium-dependent relaxations. Am. J. Physiol. 276, H1043-H1048.
148. Warburg, O., 1956. On the origin of cancer cells. Science 123, 309-314.
149. Wientjes, F.B., Segal, A.W., 1995. NADPH oxidase and the respiratory burst. Semin. Cell Biol. 6, 357-365.
150. Wood, L., Leese, M.R., Leblond, B., Woo, L.W., Ganeshapillai, D., Purohit, A., Reed, M.J., Potter, B.V., Packham, G., 2001. Inhibition of superoxide dismutase by 2-methoxyoestradiol analogues and oestrogen derivatives: structure-activity relationships. Anticancer Drug Des. 16, 209-215.
151. Wu, H.H., Thomas, J., Momand, A., 2000. P53 protein oxidation in cultured cells in response to pyrrolidine dithiocarbamate: a novel method for relating the amount of p53 oxidation in vivo to the regulation of p53-responsive genes. Biochem. J. 351, 87-93.
152. Wu, L.L., Chiou, C.C., Chang, P.Y., Wu, J.T., 2004. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin. Chim. Acta 339, 1-9.
153. Yi, J., Yang, J., He, R., Gao, F., Sang, H., Tang, X., Ye, R.D., 2004. Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling. Cancer Res. 64, 108-116.
154. Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., Susin, S.A., Petit, P.X., Mignotte, B., Kroemer, G., 1995. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182, 367-377.
155. Zdolsek, J.M., Svensson, I., 1993. Effect of reactive oxygen species on lysosomal membrane integrity. A study on a lysosomal fraction. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 64, 401-416.
156. Zhou, Y., Hileman, E.O., Plunkett, W., Keating, M.J., Huang, P., 2003. Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood 101, 4098-4104.